169 related articles for article (PubMed ID: 28751490)
1. Panel OKs CAR T Therapy for Leukemia.
Cancer Discov; 2017 Sep; 7(9):924. PubMed ID: 28751490
[TBL] [Abstract][Full Text] [Related]
2. Universal CAR T Cells Treat Leukemia.
Cancer Discov; 2017 Apr; 7(4):342. PubMed ID: 28193774
[TBL] [Abstract][Full Text] [Related]
3. From the guest editor: The rise of CAR therapy: the CD19 paradigm, and beyond. Introduction.
Sadelain M
Cancer J; 2014; 20(2):105-6. PubMed ID: 24667953
[No Abstract] [Full Text] [Related]
4. Novartis's Kymriah: Harnessing Immune System Comes With Worry About Reining in Costs.
Morrow T
Manag Care; 2017 Oct; 26(10):28-30. PubMed ID: 29068298
[TBL] [Abstract][Full Text] [Related]
5. CAR T-Cell Therapy: Pediatric Patients With Relapsed and Refractory Acute Lymphoblastic Leukemia
.
Callahan C; Baniewicz D; Ely B
Clin J Oncol Nurs; 2017 Apr; 21(2 Suppl):22-28. PubMed ID: 28315553
[TBL] [Abstract][Full Text] [Related]
6. Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia.
Liu Y; Chen X; Han W; Zhang Y
Drugs Today (Barc); 2017 Nov; 53(11):597-608. PubMed ID: 29451276
[TBL] [Abstract][Full Text] [Related]
7. CAR T-cell Therapy: A New Era in Cancer Immunotherapy.
Miliotou AN; Papadopoulou LC
Curr Pharm Biotechnol; 2018; 19(1):5-18. PubMed ID: 29667553
[TBL] [Abstract][Full Text] [Related]
8. Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Si Lim SJ; Grupp SA; DiNofia AM
Pediatr Blood Cancer; 2021 Sep; 68(9):e29123. PubMed ID: 34061452
[TBL] [Abstract][Full Text] [Related]
9. Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.
Cai B; Guo M; Wang Y; Zhang Y; Yang J; Guo Y; Dai H; Yu C; Sun Q; Qiao J; Hu K; Zuo H; Dong Z; Zhang Z; Feng M; Li B; Sun Y; Liu T; Liu Z; Wang Y; Huang Y; Yao B; Han W; Ai H
J Hematol Oncol; 2016 Nov; 9(1):131. PubMed ID: 27887660
[TBL] [Abstract][Full Text] [Related]
10. [Gene-modified T-cell therapy using chimeric antigen receptors for pediatric hematologic malignancies].
Nakazawa Y
Rinsho Ketsueki; 2016 Jun; 57(6):701-8. PubMed ID: 27384848
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice.
Luskin MR; DeAngelo DJ
Curr Hematol Malig Rep; 2017 Aug; 12(4):370-379. PubMed ID: 28656487
[TBL] [Abstract][Full Text] [Related]
12. [The CAR-T cells are here].
Croizier C; Douge A; Bay JO; Lemal R
Bull Cancer; 2018 Sep; 105(9):743-745. PubMed ID: 30119830
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform.
Magnani CF; Turazzi N; Benedicenti F; Calabria A; Tenderini E; Tettamanti S; Giordano Attianese GM; Cooper LJ; Aiuti A; Montini E; Biondi A; Biagi E
Oncotarget; 2016 Aug; 7(32):51581-51597. PubMed ID: 27323395
[TBL] [Abstract][Full Text] [Related]
14. Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.
Maus MV; Levine BL
Oncologist; 2016 May; 21(5):608-17. PubMed ID: 27009942
[TBL] [Abstract][Full Text] [Related]
15. CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?
Pegram HJ; Smith EL; Rafiq S; Brentjens RJ
Immunotherapy; 2015; 7(5):545-61. PubMed ID: 26065479
[TBL] [Abstract][Full Text] [Related]
16. The Promise and Challenges of CAR-T Gene Therapy.
Kuehn BM
JAMA; 2017 Dec; 318(22):2167-2169. PubMed ID: 29167891
[No Abstract] [Full Text] [Related]
17. CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia.
Chen R; Song XT; Chen B
Discov Med; 2015 Oct; 20(110):185-90. PubMed ID: 26562471
[TBL] [Abstract][Full Text] [Related]
18. [CAR T-cell therapy: Balance of efficacy and safety].
Kulemzin SV; Kuznetsova VV; Mamonkin M; Taranin AV; Gorchakov AA
Mol Biol (Mosk); 2017; 51(2):274-287. PubMed ID: 28537234
[TBL] [Abstract][Full Text] [Related]
19. In conversation with a pharmacist: management of CAR T-cell treatment.
Dangi-Garimella S
Am J Manag Care; 2017 Oct; 23(12 Spec No.):SP480-SP481. PubMed ID: 29087666
[No Abstract] [Full Text] [Related]
20. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
Singh N; Frey NV; Grupp SA; Maude SL
Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
